The Cleveland Clinic Foundation;Juventas Therapeutics, Inc.
发明人:
Penn, Marc S.,Aras, Rahul,Pastore, Joseph,Miller, Timothy J.,Fisher, Scott J.
申请号：
AU2014233229
公开号：
AU2014233229A1
申请日:
2014.03.15
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
Described herein are methods of treating a subject with a cardiomyopathy by administering to the subject's heart, via percutaneous retrograde coronary sinus perfusion, a pharmaceutical composition that comprises a DNA plasmid encoding SDF-1 and a pharmaceutically acceptable carrier or diluent.
